Metropolitan Digital

Google


.

The FDA’s weak drug manufacturing oversight is a potentially deadly problem

  • Written by Adrian V. Hernandez, Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
The FDA’s weak drug manufacturing oversight is a potentially deadly problemThough drug recalls are relatively uncommon in the U.S., reduced inspections increase the likelihood of manufacturing errors that slip through the cracks.AP Photo/Rafiq Maqbool

The latest setback for Johnson & Johnson’s COVID-19 vaccine was the U.S. Food and Drug Administration’s order on June 11, 2021, to discard 60 million doses th...

Read more: The FDA’s weak drug manufacturing oversight is a potentially deadly problem